Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 12, 2021 19:12 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Fourth Quarter and Full Year 2020 Financial Results

SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
January 22, 2021 16:46 ET | Source: Bragar Eagel & Squire

OBALON ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of OBLN and Encourages Investors to Contact the Firm

NEW YORK, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
November 06, 2020 16:45 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Third Quarter 2020 Financial Results

SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
August 13, 2020 07:00 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon System

SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
July 30, 2020 06:38 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Second Quarter 2020 Financial Results

SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
June 19, 2020 06:15 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces First Quarter 2020 Financial Results and Business Update

SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
May 11, 2020 08:30 ET | Source: Obalon Therapeutics, Inc.

Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment

SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and...
May 08, 2020 08:00 ET | Source: Obalon Therapeutics, Inc.

William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director

SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
April 28, 2020 09:00 ET | Source: Obalon Therapeutics, Inc.

Obalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death, With Liquid-Filled Intragastric Balloons

SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
March 25, 2020 08:30 ET | Source: Obalon Therapeutics, Inc.

Obalon Engages Canaccord Genuity to Explore Financial and Strategic Alternatives

SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...

Next Page keyboard_arrow_right